Amneal Pharmaceuticals, Inc.

Watch

Share

TickerAMRX

Sector · IndustryHealthcareDrug Manufacturers - Specialty & Generic

Activist

SecurityCommon Stock · US

CUSIP03168L105

Ask AIAsk AI about AMRX

AMRX institutional ownership changes in Q2 2026: 94 institutions opened or added positions, 66 trimmed or exited. AMRX (Amneal Pharmaceuticals, Inc.) is held by 148 institutional investors as of Q2 2026. Top institutional shareholders: BlackRock, Inc. ($459.8M), TPG GP A, LLC ($213.4M), Vanguard Portfolio Management LLC ($210.1M). Institutions were buying, on balance.

148

Holders

(6 Elite)

$2.3B

Total Value

59% (160)

Consensus

94 buying - 66 selling

Fund holdings as of Jun 30, 2026

Smart Money Verdict

View all

Loading verdict

Institutional (13F)••

Insider (Form 4)••

Activist (13D/13G)••

Congressional (STOCK Act)••

Holder Quality

••

★★★★★

Elite

••

★★★★

Strong

••

★★★

Solid

••

★★

Below

••

★

Weak

Held by 148 funds

6 elite

Who's Trading

Latest move

Source dates: Price Nov 6, 2026 · Insiders Sep 21, 2026 · Activists Aug 12, 2026 · Congress none

InsiderInsBKBUCHI J KEVINGift 20K shSep 17, 2026

InsiderInsBKBUCHI J KEVINExercise 20K shSep 11, 2026

InsiderInsBSBOYER ANDREW SGift 80K shSep 1, 2026

Checking access…

View all insider tradesView all activist filings

Top Holders

FundsInsidersCongressActivists

Holdings (148)History

AllNewIncreasedHeldDecreasedExitedFirst report

Checking access…

Fund	Action	Shares	Value	Weight	Est. P&L	Conviction
BlackRock, Inc.	Increased	26.6M(+8.3%)	$459.8M	0.0%	+88.00%	34
TGTPG GP A, LLC	Unchanged	12.3M	$213.4M	4.3%	+321.92%	0
VPVanguard Portfolio Management LLC	Increased	12.1M(+7.2%)	$210.1M	0.0%	+58.43%	33
VAVanguard Capital Management LLC	Increased	7.7M(+1.6%)	$133.5M	0.0%	+61.56%	31
State Street Corp.	Increased	7.4M(+8.3%)	$127.3M	0.0%	+129.82%	33
Dimensional Fund Advisors LP	Increased	5.8M(+1.8%)	$100.3M	0.0%	+209.29%	30
Geode Capital Management, LLC	Increased	5.1M(+13.1%)	$89M	0.0%	+125.54%	34
Morgan Stanley	Decreased	4.1M(-11.4%)	$71.1M	0.0%	+115.98%	0
Neuberger Berman Group LLC	Increased	3.9M(+5.6%)	$67.3M	0.0%	+149.97%	31
Invesco Ltd.	Increased	3.5M(+9.8%)	$60.6M	0.0%	+88.85%	32
Nuveen, LLC	Increased	3.3M(+2.5%)	$57.6M	0.0%	+127.70%	30
Allspring Global Investments Holdings, LLC	Increased	3.3M(+29.3%)	$55.9M	0.1%	+60.27%	37
Goldman Sachs Group Inc.	Increased	3M(+5.2%)	$52.2M	0.0%	+135.13%	31
Assenagon Asset Management S.A.	Decreased	2.4M(-20.3%)	$42.3M	0.1%	+64.52%	0
Charles Schwab Investment Management Inc.	Decreased	2.1M(-1.7%)	$37.2M	0.0%	+134.27%	0
Northern Trust Corp.	Increased	1.9M(+12.2%)	$33.1M	0.0%	+91.57%	32
Ameriprise Financial Inc.	Decreased	1.6M(-15.2%)	$27.4M	0.0%	+110.89%	0
VFVanguard Fiduciary Trust Co.	Increased	1.2M(+1.3%)	$20.2M	0.0%	+61.76%	29
Citadel Advisors LLC	Increased	1.1M(+93.7%)	$19.4M	0.0%	+73.54%	45
Bank of New York Mellon Corp	Increased	1M(+11.1%)	$17.6M	0.0%	+126.21%	31

Showing 1-20 of 167

Per page:

1 / 9

Loading insider trades…

Loading Congress trades…

Loading activist filings…

AMRXAmneal Pharmaceuticals, Inc.

1M3M6M1Y3Y5Y

Continue exploring

Smart money flow

Track where institutional capital is flowing

Discover new institutional entries

Fresh positions initiated this quarter

Check sector trends

Capital flows across GICS sectors

Other Healthcare stocks held by institutions

UNHUnitedHealth Group Incorporated

417 holders · $300.5B

LLYEli Lilly and Company

416 holders · $881.6B

TMOThermo Fisher Scientific Inc

401 holders · $151.5B

JNJJohnson & Johnson

398 holders · $415.6B

DHRDanaher Corporation

395 holders · $98.9B

ISRGIntuitive Surgical, Inc.

394 holders · $111.8B

MRKMerck & Company, Inc.

391 holders · $230.3B

ABBVAbbVie Inc.

386 holders · $303.9B

BSXBoston Scientific Corporation

386 holders · $52.4B

ABTAbbott Laboratories

383 holders · $114.2B

Questions investors ask about AMRX

Who owns AMRX?

148 institutional investors held AMRX on June 30, 2026, led by BlackRock, Inc. ($459.8M), TPG GP A, LLC ($213.4M) and Vanguard Portfolio Management LLC ($210.1M).

How many hedge funds hold AMRX?

148 institutional investors reported AMRX in their 13F filings for the quarter ended June 30, 2026, $2.3B in all. 6 of them are rated Elite.

Are institutions buying or selling AMRX?

Buying, on balance. In Q2 2026, 94 institutions opened or added to positions in AMRX and 66 institutions trimmed or exited.

High Conviction Moves-Smart Money Convergence-Fund Consensus-Double-Down Detection

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer